St. Michaels Hospital

Toronto, Ontario m5B 1W8

23 studies enrolling now · 247 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Acute Coronary Syndrome, Acute Heart Failure, Acute Ischemic Stroke, Acute Kidney Injury, Acute Lung Injury, Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome (ARDS), Acute Spinal Cord Injury, Acute Spinal Paralysis

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy — Recruiting now
• ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Recruiting now
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant — Recruiting now
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
• The TRICURE EFS Study — Recruiting now
• EXtubation Related Complications - the EXTUBE Study (EXTUBE) — Recruiting now
• International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF) — Recruiting now
• LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• The STOP-MED CTRCD Trial — Recruiting now
• Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial — Recruiting now
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• Clinical Study of the inQB8 TTVR System (The MonarQ Study) — Recruiting now
• Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas — Recruiting now
• Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock — Recruiting now
• J-Valve Transfemoral Pivotal Study — Recruiting now
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance — Recruiting now
• Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) — Recruiting now
• Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement — Recruiting now
• SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
• PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2 — Completed
• Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation — Running, not enrolling
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis — Running, not enrolling
• Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial — Running, not enrolling
• Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates — Running, not enrolling
• Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA — Running, not enrolling
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
• Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B — Running, not enrolling
• (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis — Running, not enrolling
• MitraClip REPAIR MR Study — Running, not enrolling
• 2019-06 TRISCEND Study — Running, not enrolling
• ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation — Enrolling by invitation
• Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
• (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis — Completed
• A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) — Completed
• Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia — Completed
• Evaluation of a Simple-Prep Controlled Embolic — Running, not enrolling
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer — Running, not enrolling
• PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease — Completed